Understanding Why People Decline to Participate in Trials
Author Information
Author(s): Eborall Helen C, Stewart Marlene CW, Cunningham-Burley Sarah, Price Jackie F, Fowkes F Gerry R
Primary Institution: Department of Health Sciences, University of Leicester
Hypothesis
What are the reasons for declining to participate in a primary prevention randomized controlled trial?
Conclusion
The study found that reasons for declining participation often relate to perceived necessity and risk, while reasons for stopping medication include side effects and changes in health status.
Supporting Evidence
- Participants who declined often cited mundane reasons or a lack of perceived necessity.
- Some participants stopped medication due to side effects or changes in their health status.
- The study highlights the importance of understanding participant perspectives to improve trial recruitment.
Takeaway
Some people don't want to join medical trials because they think they don't need to, or they're scared of the risks. Others who start the trial might stop if they feel sick or have to take other medicines.
Methodology
Semi-structured interviews and a focus group with participants who declined or stopped trial medication.
Potential Biases
Response bias due to self-selection in the qualitative study.
Limitations
The sample may not represent all individuals who declined or stopped medication due to the opt-in recruitment process.
Participant Demographics
Participants were aged 55 to 77, predominantly female, and of 'White British' ethnicity with varied socioeconomic backgrounds.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website